Position in EDIT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,385,125
+$2,064,524 QoQ
Shares Held
1,370,497
+112.7% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. EDIT ranks #71 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in EDIT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,385,125 | 1,370,497 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,320,601 | 644,197 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,386,508 | 687,755 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,688,750 | 767,615 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,183,934 | 1,020,636 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,359,093 | 1,070,153 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,282,830 | 376,197 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $214,306 | 45,890 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $156,799 | 21,132 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $288,077 | 36,933 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $228,588 | 27,775 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $407,508 | 56,208 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $290,598 | 32,762 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $930,058 | 48,899 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $375,045 | 14,126 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $879,728 | 21,415 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $919,776 | 16,239 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $981,540 | 23,370 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,148,542 | 16,382 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $682,699 | 24,330 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,055,769 | 35,692 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $790,939 | 39,886 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||